Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL

Cytotherapy

Volumn 10, Issue 3, 2008, Pages 265-274

  Jiang, W ^a   Zhang, J ^a   Tian, Z ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Gene transfer; Interleukin 15; Natural killer cell line; Natural killer cells

Indexed keywords

BIM PROTEIN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; PERFORIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN NOXA; APOPTOSIS REGULATORY PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; ELECTROPORATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL LINE; CYTOLOGY; CYTOTOXICITY; GENE VECTOR; GENETICS; IMMUNOLOGY; LIVER CELL CARCINOMA; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; HUMANS; INTERLEUKIN-15; KILLER CELLS, NATURAL; TRANSDUCTION, GENETIC;

EID: 42449139629     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240801965156     Document Type: Article

References (38)

1. Roder, JC and Pross, HF. (1982) The biology of the human natural killer cell. J Clin Immunol, 24, pp. 249-263.
2. Cerwenka, A. and Lanier, LL. (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol, 11, pp. 41-49.
3. Robertson, MJ and Ritz, J. (1990) Biology and clinical relevance of human natural killer cells. Blood, 76, pp. 2421-2438.
4. Yawata, M., Yawata, N. and McQueen, KL (2002) Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics, 54, pp. 542-550.
5. Lanier, LL. (1998) NK cell receptors. Annu Rev Immunol, 16, pp. 359-393.
6. Moretta, A., Bottino, C. and Vitale, M. (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol, 14, pp. 619-648.
7. Biassoni, R., Cantoni, C. and Marras, D. (2003) Human natural killer cell receptors: Insights into their molecular function and structure. J Cell Mol Med, 74, pp. 376-387.
8. Biron, CA, Nguyen, KB and Pien, GC (1999) Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol, 17, pp. 189-220.
9. Soloski, MJ. (2001) Recognition of tumor cells by the innate immune system. Curr Opin Immunol, 132, pp. 154-162.
10. Ruggeri, L., Mancusi, A. and Capanni, M. (2005) Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr Opin Immunol, 17, pp. 211-217.
11. Yannelli, JR and Wroblewski, JM. (2004) On the road to a tumor cell vaccine: 20 years of cellular immunotherapy. Vaccine, 23, pp. 97-113.
12. Grabstein, KH, Eisenman, J. and Shanebeck, K. (1994) Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science, 264, pp. 965-968.
13. Burton, JD, Bamford, RN and Peters, C. (1994) A lymphokine, provisionally designated interleukin-T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA, 91, pp. 4935-4939.
14. Carson, WE, Giri, JG and Lindemann, MJ (1994) Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med, 180, pp. 1395-1403.
15. Anderson, DM, Abdieh, M. and Bertles, J. (1995) Functional characterization of human interleukin-15 receptor α chain and close linkage of IL-15RA and IL-2RA genes. J Biol Chem, 270, pp. 29862-29869.
16. Waldmann, TA and Tagaya, Y. (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol, 17, pp. 19-49.
17. + hematopoietic progenitor cells. Blood, 87, pp. 2632-2640.
18. Bazan, JF. (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA, 87, pp. 6934-6938.
19. Fehniger, TA and Caligiuri, MA. (2001) Interleukin 15: Biology and relevance to human disease. Blood, 97, pp. 14-32.
20. He, YG, Mayhew, E. and Mellon, J. (2004) Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells. Invest Ophthalmol Vis Sci, 45, pp. 4240-4246.
21. Grund, EM, Spyropoulos, DD and Watson, DK (2004) Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. J Biol Chem, 280, pp. 4772-4778.
22. Tinhofer, I., Marschitz, I. and Henn, T. (2000) Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood, 95, pp. 610-618.
23. Zhang, J., Sun, R. and Wei, H. (2004) Characterization of interleukin-15 gene-modified human natural killer cells: Implications for adoptive cellular immunotherapy. Haematologica, 89, pp. 338-347.
24. Zhang, C., Zhang, JH and Niu, JF (2008) Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine, 42, pp. 128-136.
25. Robertson, MJ, Cochran, KJ and Cameron, C. (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol, 24, pp. 406-415.
26. Maasho, K., Marusina, A. and Reynolds, NM (2004) Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system™. J Immunol Methods, 284, pp. 133-140.
27. Marusina, AI, Kim, DK and Lieto, LD (2005) GATA-3 is an important transcription factor for regulating human NKG2A gene expression. J Immunol, 174, pp. 2152-2159.
28. Gross, C., Schmidt-Wolf, IG and Nagaraj, S. (2003) Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/ CD56 on primary natural killer cells. Cell Stress Chaperones, 8, pp. 348-360.
29. Grund, EM and Muise-Helmericks, RC. (2005) Cost efficient and effective gene transfer into the human natural killer cell line, NK92. J Immunol Methods, 296, pp. 31-36.
30. Xiong, C., Hixson, PM and Mendoza, LH (2005) Cloning and expression of rabbit interleukin-15. Vet Immunol Immunopathol, 107, pp. 131-141.
31. Huntington, ND, Puthalakath, H. and Gunn, P. (2007) Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol, 8, pp. 856-863.
32. Arai, S., Kindy, K. and Swearingen, M. (2003) Phase I study of adoptive immunotherapy using the cytotoxic natural killer (NK) cell line, NK-92, for treatment of advanced renal cell carcinoma and malignant melanoma. Blood, 102, p. 2566.
33. Arai, S. and Klingemann, HG. (2005) Natural killer cells: Can they be useful as adoptive immunotherapy for cancer?. Expert Opin Biol Ther, 5, pp. 163-172.
34. Suck, G. (2006) Novel approaches using natural killer cells in cancer therapy. Semin Cancer Biol, 16, pp. 412-418.
35. Tam, YK, Maki, G. and Miyagawa, B. (1999) Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum Gene Ther, 10, pp. 1359-1373.
36. Cooper, MA, Bush, JE and Fehniger, TA (2002) In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood, 100, pp. 3633-3638.
37. Ranson, T., Vosshenrich, CA and Corcuff, E. (2003) IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood, 101, pp. 4887-4893.
38. + T cells for immunotherapy. Cytotherapy, 7, pp. 23-35.